CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
Clinical trial NCT03152708 · UNKNOWN
Trial details
- NCT number
- NCT03152708
- Sponsor
- CANbridge Life Sciences Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.